Comparative Pharmacology
Head-to-head clinical analysis: CENTANY versus SSD AF.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CENTANY versus SSD AF.
CENTANY vs SSD AF
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mupirocin binds to isoleucyl-tRNA synthetase, inhibiting bacterial protein synthesis.
Silver sulfadiazine exerts bactericidal activity by releasing silver ions that bind to bacterial DNA and cell wall components, causing disruption of cellular respiration and DNA replication. It also inhibits bacterial cell wall synthesis via the sulfadiazine component.
Apply a thin layer to affected area twice daily for 10 days. For perioral dermatitis, apply once daily.
Apply a thin layer topically once or twice daily to affected area.
None Documented
None Documented
8-10 minutes in serum; prolonged to 15-20 minutes in patients with renal impairment. Clinical context: Rapidly cleared, infrequent dosing intervals (e.g., every 20 minutes during procedure).
Terminal elimination half-life is 6–8 hours; clinically, this supports twice-daily dosing in most patients.
Primarily excreted unchanged in urine via glomerular filtration and tubular secretion (85-90% renal); minor biliary/fecal elimination (<5%).
Renal: ~10% as unchanged drug; biliary/fecal: ~90% as metabolites.
Category C
Category C
Topical Antibiotic
Topical Antibiotic